President Joe Biden selected Vanderbilt University’s medicine chair Kimryn Rathmell to serve as the next director of the National Cancer Institute, the White House announced Friday.
Aneuploidy drives gain-of-function characteristics in cells expressing mutant p53, a Vanderbilt University team showed.
FDA slaps a hold on one of Amgen’s early-stage cancer drugs
Vanderbilt University has signed separate licensing and research collaboration agreements with Lundbeck, a global pharmaceutical company based in Denmark, to develop a novel approach for treating schizophrenia.